Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05261490 |
Title | Study of TTI-622 in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer |
Recruitment | Terminated |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Trillium Therapeutics Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |